Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
03.05.2024 |
02.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
2 495.00
|
2 350.00
|
2 760.00
|
2 620.00
|
|
|
3 085 114 665.00
|
|
|
|
2 950.00
|
2 860.00
|
3 100.00
|
2 860.00
|
|
|
959 178 880.00
|
|
|
|
2 880.00
|
2 830.00
|
2 910.00
|
2 885.00
|
|
|
402 134 705.00
|
|
|
|
3 030.00
|
2 810.00
|
3 030.00
|
2 880.00
|
|
|
874 260 600.00
|
|
|
|
3 095.00
|
2 985.00
|
3 095.00
|
3 020.00
|
|
|
422 535 515.00
|
|
|
|
3 150.00
|
3 035.00
|
3 150.00
|
3 080.00
|
|
|
236 270 640.00
|
|
|
|
3 120.00
|
3 100.00
|
3 170.00
|
3 150.00
|
|
|
384 627 185.00
|
|
|
|
2 975.00
|
2 970.00
|
3 125.00
|
3 120.00
|
|
|
660 347 835.00
|
|
|
|
3 020.00
|
2 935.00
|
3 060.00
|
2 935.00
|
|
|
443 150 775.00
|
|
|
|
3 045.00
|
2 985.00
|
3 045.00
|
3 020.00
|
|
|
235 583 430.00
|
|
CrystalGenomics Inc. develops pharmaceutical and agricultural products by structure-based drug discovery technology. The Company also provides structural proteomic analysis services for helping drug discovery process.